This latest installment of the HDYO Research Video Series breaks down the recent HD Buzz article regarding details of Novartis' decision to end the development of Branaplam for HD.
To read the full article, visit https://en.hdbuzz.net/338
For further details of other research news, visit our playlist: https://www.youtube.com/playlist?list=PLfha5f75-ixIGTqdQSa-u-4sjMPFyYffn
Thanks to our sponsors: uniQure, Sage Therapeutics, Neurocrine Biosciences and Teva Pharmaceuticals.